{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:14:53Z","timestamp":1778591693200,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001458","name":"American Kennel Club Canine Health Foundation","doi-asserted-by":"publisher","award":["02257"],"award-info":[{"award-number":["02257"]}],"id":[{"id":"10.13039\/100001458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ymgme.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:22:57Z","timestamp":1555507377000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs"],"prefix":"10.1016","volume":"127","author":[{"given":"Natalie A.","family":"Villani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tendai","family":"Mhlanga-Mutangadura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.04.003_bb0005","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Mole","year":"2011"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0010","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","article-title":"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses","volume":"1832","author":"Warrier","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0015","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.24815","article-title":"Efficacy of phosphodiesterase-4 inhibitors in juvenile batten disease (CLN3)","volume":"80","author":"Aldrich","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0020","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1046\/j.1460-9568.2002.02299.x","article-title":"Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system","volume":"16","author":"Bertamini","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2008.02.016","article-title":"Moving towards therapies for juvenile batten disease?","volume":"211","author":"Cooper","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0030","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1523\/JNEUROSCI.19-07-02556.1999","article-title":"Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment","volume":"19","author":"Cooper","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2014.01.003","article-title":"Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease","volume":"65","author":"Damme","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/13816810.2014.886271","article-title":"Immunosuppressive treatment for retinal degeneration in juvenile neuronal Ceroid Lipofuscinosis (juvenile batten disease)","volume":"36","author":"Drack","year":"2015","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0045","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/cmdc.200600144","article-title":"Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis","volume":"1","author":"Elger","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0050","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/0883073813494480","article-title":"Treatment of the Ppt1(\u2212\/\u2212) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine","volume":"28","author":"Finn","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176526","article-title":"A tailored mouse model of CLN2 disease: a nonsense mutant for testing personalized therapies","volume":"12","author":"Geraets","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0060","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.bbadis.2013.05.026","article-title":"Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)","volume":"1832","author":"Hawkins-Salsbury","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2007.08.017","article-title":"Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"29","author":"Katz","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1097-4547(19971001)50:1<123::AID-JNR13>3.0.CO;2-C","article-title":"Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid-lipofuscinosis","volume":"50","author":"Katz","year":"1997","journal-title":"J. Neurosci. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2019.04.003_bb0075","first-page":"682","article-title":"CLN2 disease (classic late infantile neuronal Ceroid Lipofuscinosis)","volume":"13","author":"Kohlschutter","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2007.09.012","article-title":"Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile batten disease","volume":"209","author":"Kovacs","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0085","first-page":"351","article-title":"Finding the most appropriate mouse model of juvenile CLN3 (batten) disease for therapeutic studies: the importance of genetic background and gender","volume":"8","author":"Kovacs","year":"2015","journal-title":"Dis"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/brain\/awv026","article-title":"Translational neurophysiology in sheep: measuring sleep and neurological dysfunction in CLN5 batten disease affected sheep","volume":"138","author":"Perentos","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2017.06.012","article-title":"Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice","volume":"106","author":"Petkau","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0100","first-page":"621","article-title":"NCL in animal models","volume":"107","author":"Ruther","year":"2010","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/mcne.2001.1099","article-title":"Retinal pathology and function in a Cln3 knockout mouse model of juvenile neuronal Ceroid Lipofuscinosis (batten disease)","volume":"19","author":"Seigel","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J. Neurosurg. Pediatrics"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.stem.2009.05.022","article-title":"Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"5","author":"Tamaki","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0125","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/MCB.26.6.2309-2316.2006","article-title":"Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease","volume":"26","author":"Tang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.expneurol.2004.03.006","article-title":"Clenbuterol retards loss of motor function in motor neuron degeneration mice","volume":"187","author":"Zeman","year":"2004","journal-title":"Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2019.04.003_bb0135","first-page":"655","article-title":"Juvenile NCL (CLN3 disease): emerging disease-modifying therapeutic","volume":"13","author":"Augustine","year":"2016","journal-title":"Strategies Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/jnc.13987","article-title":"Gemfibrozil, food and drug administration-approved lipid-lowering drug, increases longevity in mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"141","author":"Ghosh","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0145","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","article-title":"Fingolimod and Teriflunomide attenuate Neurodegeneration in mouse models of neuronal Ceroid Lipofuscinosis","volume":"25","author":"Groh","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0150","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1021\/acs.jmedchem.5b01020","article-title":"Progress in the development of small molecule therapeutics for the treatment of neuronal Ceroid Lipofuscinoses (NCLs)","volume":"59","author":"Kinarivala","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ae907882-62e0-4803-8c00-35b30a649fe9","article-title":"Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation","volume":"8","author":"Mirza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0160","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","article-title":"Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis","volume":"35","author":"Roberts","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0165","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","article-title":"Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis","volume":"114","author":"Vuillemenot","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","article-title":"Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease","volume":"146","author":"Whiting","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0185","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of Intraventricular Cerliponase Alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nbd.2017.08.017","article-title":"Canine neuronal ceroid lipofuscinoses: promising models for preclinical testing of therapeutic interventions","volume":"108","author":"Katz","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/age.12629","article-title":"Neuronal ceroid lipofuscinosis in salukis is caused by a single base pair insertion in CLN8","volume":"49","author":"Lingaas","year":"2018","journal-title":"Anim. Genet."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/104063870301500509","article-title":"Neuronal ceroid-lipofuscinosis in a Labrador Retriever","volume":"15","author":"Rossmeisl","year":"2003","journal-title":"J. Vet. Diagn. Investig."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jvim.14632","article-title":"Homozygous PPT1 splice donor mutation in a cane Corso dog with neuronal Ceroid Lipofuscinosis","volume":"31","author":"Kolicheski","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbrc.2004.12.038","article-title":"A mutation in the CLN8 gene in English setter dogs with neuronal ceroid-lipofuscinosis","volume":"327","author":"Katz","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0215","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/jvim.13971","article-title":"Australian cattle dogs with neuronal Ceroid Lipofuscinosis are homozygous for a CLN5 nonsense mutation previously identified in border collies","volume":"30","author":"Kolicheski","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0891-5849(89)90007-5","article-title":"The autofluorescent products of lipid peroxidation may not be lipofuscin-like","volume":"7","author":"Eldred","year":"1989","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0047-6374(96)01817-9","article-title":"Formation of lipofuscin-like fluorophores by reaction of retinal with photoreceptor outer segments and liposomes","volume":"92","author":"Katz","year":"1996","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0047-6374(84)90137-4","article-title":"Lipofuscin accumulation resulting from senescence and vitamin E deficiency: spectral properties and tissue distribution","volume":"25","author":"Katz","year":"1984","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0047-6374(89)90065-1","article-title":"Development of lipofuscin-like fluorescence in the retinal pigment epithelium in response to protease inhibitor treatment","volume":"49","author":"Katz","year":"1989","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0240","first-page":"3161","article-title":"Iron-induced accumulation of lipofuscin-like fluorescent pigment in the retinal pigment epithelium","volume":"34","author":"Katz","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygeno.2005.06.005","article-title":"A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs","volume":"86","author":"Melville","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2015.04.001","article-title":"Golden retriever dogs with neuronal ceroid lipofuscinosis have a two-base-pair deletion and frameshift in CLN5","volume":"115","author":"Gilliam","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0255","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12917-014-0181-z","article-title":"A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese crested dog with neuronal ceroid lipofuscinosis","volume":"10","author":"Guo","year":"2015","journal-title":"BMC Veterinary Res."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0260","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymgme.2016.05.008","article-title":"Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas","volume":"118","author":"Ashwini","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0265","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jnr.23710","article-title":"The Chihuahua dog: a new animal model for neuronal ceroid lipofuscinosis CLN7 disease?","volume":"94","author":"Faller","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/age.12449","article-title":"MFSD8 single-base pair deletion in a Chihuahua with neuronal ceroid lipofuscinosis","volume":"47","author":"Karli","year":"2016","journal-title":"Anim. Genet."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1292\/jvms.15-0279","article-title":"Real-time PCR genotyping assay for canine progressive rod-cone degeneration and mutant allele frequency in toy poodles, Chihuahuas and miniature dachshunds in Japan","volume":"78","author":"Kohyama","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0280","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1167\/iovs.09-5142","article-title":"An ADAMTS17 splice donor site mutation in dogs with primary lens luxation","volume":"51","author":"Farias","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007361","article-title":"Frequency and distribution of 152 genetic disease variants in over 100,000 mixed breed and purebred dogs","volume":"14","author":"Donner","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0290","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1463-5224.2011.00892.x","article-title":"ADAMTS17 mutation associated with primary lens luxation is widespread among breeds","volume":"14","author":"Gould","year":"2011","journal-title":"Vet. Ophthalmol."},{"issue":"2000\u22122011","key":"10.1016\/j.ymgme.2019.04.003_bb0295","article-title":"Neuronal ceroid lipofuscinosis in border collie dogs in Japan: clinical and molecular epidemiological study","volume":"2012","author":"Mizukami","year":"2012","journal-title":"Thescientificworldjournal"},{"key":"10.1016\/j.ymgme.2019.04.003_bb0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2005.11.005","article-title":"A mutation in the cathepsin D gene (CTSD) in American bulldogs with neuronal ceroid lipofuscinosis","volume":"87","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.04.003_bb0305","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1939-1676.2005.tb02657.x","article-title":"A variant form of neuronal ceroid lipofuscinosis in American bulldogs","volume":"19","author":"Evans","year":"2005","journal-title":"J. Vet. Intern. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921930085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921930085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:48:27Z","timestamp":1778590107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921930085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S109671921930085X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.04.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}